https://nrd167inhibitor.com/fi....bromyalgia-an-revise
The substantial economic burden of COPD exacerbations, pneumonia, and hospitalizations in Chinese COPD patients was highlighted in this study. There was a notable decrease in the economic impact when the influenza vaccine and/or the 23-valent pneumococcal polysaccharide vaccine (PPSV23) were administered. We have observed a correlation between the study's data and the suggestion to provide Chinese COPD patients with both the influenza vaccine and PPSV23. Evidence from our study
Like
Comment
Share
